SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD), the most frequent liver disease in the Western world, is a common hepatic manifestation of metabolic syndrome (MetS). A specific cure has not yet been identified, and its treatment is currently based on risk factor therapy. Given that the initial accumulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirarchi, Luigi, Amodeo, Simona, Citarrella, Roberto, Licata, Anna, Soresi, Maurizio, Giannitrapani, Lydia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998221/
https://www.ncbi.nlm.nih.gov/pubmed/35409028
http://dx.doi.org/10.3390/ijms23073668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998221/
https://www.ncbi.nlm.nih.gov/pubmed/35409028
http://dx.doi.org/10.3390/ijms23073668

Ejemplares similares